They now offer expanded coverage of continuous glucose monitors (CGM) for patients with type 1 diabetes. It's great to see advances in technology that have tangible impact on disease management.
Last month, the American Diabetes Association (ADA) published its 2009 Standards of Medical Care in Diabetes. The new standards recommends the use of CGM in the following ways:
- Continuous glucose monitoring (CGM) in conjunction with intensive insulin regimens can be a useful tool to lower A1C in selected adults (age ≥25 years) with type 1 diabetes.
- Although the evidence for A1C lowering is less strong in children, teens, and younger adults, CGM may be helpful in these groups. Success correlates with adherence to ongoing use of the device.
- CGM may be a supplemental tool to SMBG in those with hypoglycemia unawareness and/or frequent hypoglycemic episodes.
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:1464–1476, 2008
I do hope that other insurance companies follow their lead.ReplyDelete
In my opinion we won't see significant improvement in our healthcare system (including reduced costs) until insurance companies pay adequately for treatment of chronic diseases instead of just paying for treatment of outcomes. I'm ever hopeful this will happen.